Growth hormone/insulin-like factor 1 axis recovery after liver transplantation: A preliminary prospective study

Liver Transplantation

Volumn 10, Issue 5, 2004, Pages 692-698

  Bassanello, Marco ^a   de Palo, Elio Franco ^a   Lancerin, Federica ^a   Vitale, Alessandro ^a   Gatti, Rosalba ^a   Montin, Umberto ^a   Ciarleglio, Francesco Antonio ^a   Senzolo, Marco ^a   Burra, Patrizia ^a   Brolese, Alberto ^a   Zanus, Giacomo ^a   D'Amico, Davide Francesco ^a   Cillo, Umberto ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; ANTITHROMBIN III; ASPARTATE AMINOTRANSFERASE; CYCLOSPORIN; GAMMA GLUTAMYLTRANSFERASE; GROWTH HORMONE; LACTIC ACID; SOMATOMEDIN C; STEROID; TACROLIMUS;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GRAFT REJECTION; HORMONE BLOOD LEVEL; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER GRAFT; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; FEMALE; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; REPERFUSION;

EID: 2442618426     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20111     Document Type: Article

References (30)

1. Baruch Y. The liver: a large endocrine gland. J Hepatol 2000;32: 505-507.
2. Ross RJM, Jenkins RC. Definition of growth hormone resistance. J Endocrinol Invest 1998;21:2-5.
3. Guler HP, Zapf J, Froesh ER. Short-term metabolic effects of recombinant human insulin-like growth factor 1 in healthy adults. N Engl J Med 1987;317:137-140.
4. De Palo EF, Bassanello M, Lancerin F, Spinella P, Gatti R, D'Amico D, et al. GH/IGF system, cirrhosis and liver transplantation. Clin Chim Acta 2001;310:31-37.
5. Moeller S, Juul A, Becker U, Flyvbjerg A, Skakkebaek NE, Henriksen JH. Concentrations, release, and disposal of insulin-growth factor (IGF)-binding proteins (IGFBP), IGF 1, and growth hormone in different vascular beds in patients with liver cirrhosis. J Clin Endocrinol Metab 1995;80:1148-1157.
6. Donaghy A, Ross R, Gimson A, Hughes SC, Holly J, Williams R. Growth hormone, insulin-like growth factor-1, and insulin-like growth factor binding proteins 1 and 3 in chronic liver disease. Hepatology 1995;21:680-688.
7. Caregaro L, Alberino F, Amodio P, Merkel C, Angeli P, Plebani M, et al. Nutritional and prognostic significance of insulin-like growth factor 1 in patients with liver cirrhosis. Nutrition 1997; 13:185-190.
8. Baruch Y, Assy N, Amit T, Krivoy N, Strickovsky D, Orr ZS, et al. Spontaneous pulsatility and pharmacokinetics of growth hormone in liver cirrhotic patients. J Hepatol 1998;29:559-564.
9. Holt RIG, Jones JS, Stone NM, Baker AJ, Miell JP. Sequential changes in insulin-like growth factor I (IGF-I) and IGF-binding proteins in children with end-stage liver disease before and after successful orthotopic liver transplantation. J Clin Endocrinol Metab 1996;81:160-168.
10. Maes M, Sokal E, Otte JB. Growth factors in children with end-stage liver disease before and after liver transplantation: a review. Pediatr Transplant 1997;1:171-175.
11. Holt RIG, Baker AJ, Jones JS, Miell JP. The insulin-like growth factor and binding protein axis in children with end-stage liver disease before and after orthotopic liver transplantation. Pediatr Transplant 1998;2:76-84.
12. Infante D, Tormo R, De Kolster CC, Potau N, Martinez V, Broto J, et al. Changes in growth, growth hormone, and insulin-like growth factor-I (IGF-I) after orthotopic liver transplantation. Pediatr Surg Int 1998;13:323-326.
13. Schalch DS, Kalayoglu M, Pirsh JD, Yang H, Raslich M, Rajpal S. Serum insulin-like growth factors and their binding proteins in patients with hepatic failure and after liver transplantation. Metabolism 1998;47:200-206.
14. Seehofer D, Steinmueller T, Graef KJ, Rayes N, Wiegand W, Tullius SG, et al. Pituitary function test and endocrine status in patient with cirrhosis of the liver before and after hepatic transplantation. Ann Transplant 2002;7:32-37.
15. Weber MM, Auernhammer CJ, Lee PDK, Engelhardt D, Zachoval R. Insulin-like growth factors and insulin-like growth factor binding proteins in adult patients with severe liver disease before and after orthotopic liver transplantation. Horm Res 2002;57:105-112.
16. Doyle HR, Marino IR, Jabbour N, Zetti G, McMichael J, Mitchell S, et al. Early death or retransplantation in adults after orthotopic liver transplantation. Transplantation 1994;57:1028-1036.
17. Ploeg RJ, D'Alessandro A, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann, et al. Risk factors for primary dysfunction after liver transplantation - a multivariate analysis. Transplantation 1993; 55:807-813.
18. De Palo EF, Gatti R, Lancerin F, Cappellin E, Sartorio A, Spinella P. The measurement of IGF-I concentration in random urine samples. Clin Chem Lab Med 2002;40:574-578.
19. Holly JMP, Wass JAH. Insulin-like growth factors: autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developments. J Endocrinol 1989;122:611-618.
20. Cotteril AM, Mendel P, Holly JMP, Timmins AG, Camacho-Hubner C, Hughes SC, et al. The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery. Clinical Endocrinology 1996;44:91-101.
21. Moeller S, Becker U, Juul A, Skakkebaek NE, Christensen E. Prognostic value of insulin-like growth factor I and its binding protein in patients with alcohol-induced liver disease. Hepatology 1996;23:1073-1078.
22. Scharf JG, Schmitz F, Frystyk J, Skjaerbaek C, Moesus H, Blum WF, et al. Insulin-like growth factor-I serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease. J Hepatol 1996;25:689-699.
23. Blomsma MC, de Knegt RJ, Dullaart RPF, Jansen PLM. Insulin-like growth factor-I in liver cirrhosis. J Hepatol 1997;27: 1133-1138.
24. Inaba T, Saito H, Inoue T, Han I, Furukawa S, Matsuda T, et al. Growth hormone/insulin-like factor I axis alterations contribute to disturbed protein metabolism in cirrhosis patients after hepatectomy. J Hepatol 1999;31:271-276.
25. Shimada M, Matsumata T, Yamamoto K, Taketomi A, Shirabe K, Takenaka K, et al. The role of growth hormone, somatostatin and glucagons in hepatic resection. Hepatogastroenterology 1998;45:178-183.
26. Russell WE, D'Ercole AJ, Underwood LE. Somatomedin C/insulin-like growth factor I during liver regeneration in the rat. American journal of Physiology 1985;248:E618-E623.
27. Unterman TG, Phillips LS. Circulating somatomedin activity during hepatic regeneration. Endocrinology 1986;119:185-192.
28. Deschenes M, Belle SH, Krom RAF, Zetterman RK, Lake JR. Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Transplantation 1998;66:302-310.
29. Olthoff KM. Molecular pathways of regeneration and repair after liver transplantation. World J Surg 2002;26:831-837.
30. Ghahary A, Minuk GY, Luo J, Gauthier T, Murphy LJ. Effects of partial hepatectomy on hepatic insulin-like growth factor binding protein-1 expression. Hepatology 1992;15:1125-1131.